BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 823852)

  • 1. Combination vasodilator therapy for severe chronic congestive heart failure.
    Chatterjee K; Drew D; Parmley WW; Klausner SC; Polansky J; Zacherle B
    Ann Intern Med; 1976 Oct; 85(4):467-70. PubMed ID: 823852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasodilator therapy for chronic left ventricular failure.
    Kovick RB; Tillisch JH; Berens SC; Bramowitz AD; Shine KI
    Circulation; 1976 Feb; 53(2):322-8. PubMed ID: 812614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasodilators in the treatment of congestive heart failure.
    Ciafone RA
    Conn Med; 1983 Oct; 47(10):614-8. PubMed ID: 6414758
    [No Abstract]   [Full Text] [Related]  

  • 4. Current indications for vasodilator therapy for left ventricular failure.
    Franciosa JA
    Compr Ther; 1985 Mar; 11(3):39-46. PubMed ID: 2983926
    [No Abstract]   [Full Text] [Related]  

  • 5. Combined oral hydralazine-nitrate therapy in left ventricular failure. Hemodynamic equivalency to sodium nitroprusside.
    Pierpont GL; Cohn JN; Franciosa JA
    Chest; 1978 Jan; 73(1):8-13. PubMed ID: 620563
    [No Abstract]   [Full Text] [Related]  

  • 6. [Vasodilator agents in the treatment of heart failure].
    Prati PL; Manfrin M
    G Ital Cardiol; 1978; 8(1):1-11. PubMed ID: 415927
    [No Abstract]   [Full Text] [Related]  

  • 7. Vasodilator therapy of congestive heart failure.
    Cohn JN
    Adv Intern Med; 1980; 26():293-315. PubMed ID: 6784453
    [No Abstract]   [Full Text] [Related]  

  • 8. Afterload reduction and cardiac performance. Physiologic basis of systemic vasodilators as a new approach in treatment of congestive heart failure.
    Mason DT
    Am J Med; 1978 Jul; 65(1):106-25. PubMed ID: 99030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic advantage of combined administration of hydralazine orally and nitrates nonparenterally in the vasodilator therapy of chronic heart failure.
    Massie B; Chatterjee K; Werner J; Greenberg B; Hart R; Parmley WW
    Am J Cardiol; 1977 Nov; 40(5):794-801. PubMed ID: 411364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study.
    Cohn JN; Archibald DG; Ziesche S; Franciosa JA; Harston WE; Tristani FE; Dunkman WB; Jacobs W; Francis GS; Flohr KH
    N Engl J Med; 1986 Jun; 314(24):1547-52. PubMed ID: 3520315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasodilator treatment with isosorbide dinitrate and hydralazine in chronic heart failure.
    Massie BM; Kramer B; Shen E; Haughom F
    Br Heart J; 1981 Apr; 45(4):376-84. PubMed ID: 7225252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrasting hemodynamic responses in severe heart failure: comparison of captopril and other vasodilator drugs.
    Packer M; Medina N; Yushak M
    Am Heart J; 1982 Nov; 104(5 Pt 2):1215-23. PubMed ID: 6753552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic assessment of oral peripheral vasodilator therapy in chronic congestive heart failure: prolonged effectiveness of isosorbide dinitrate.
    Williams DO; Bommer WJ; Miller RR; Amsterdam EA; Mason DT
    Am J Cardiol; 1977 Jan; 39(1):84-90. PubMed ID: 318795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outpatient vasodilator therapy of congestive heart failure. Consideration of agents at rest and during exercise.
    Chatterjee K; Massie B; Rubin S; Gelberg H; Brundage BH; Ports TA
    Am J Med; 1978 Jul; 65(1):134-45. PubMed ID: 99031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained hemodynamic efficacy of therapy tailored to reduce filling pressures in survivors with advanced heart failure.
    Steimle AE; Stevenson LW; Chelimsky-Fallick C; Fonarow GC; Hamilton MA; Moriguchi JD; Kartashov A; Tillisch JH
    Circulation; 1997 Aug; 96(4):1165-72. PubMed ID: 9286945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of cardiac failure with vasodilators (author's transl)].
    Imhof P
    Schweiz Rundsch Med Prax; 1978 May; 67(22):219-29. PubMed ID: 418395
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of isosorbide dinitrate in management of chronic congestive heart failure.
    Parmley WW
    Am Heart J; 1985 Jul; 110(1 Pt 2):264-8. PubMed ID: 3893081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasodilator therapy in refractory congestive heart failure: a comparative analysis of hemodynamic and noninvasive studies.
    Haq A; Rakowski H; Baigrie R; McLaughlin P; Burns R; Tihal H; Hilton D; Feiglin D
    Am J Cardiol; 1982 Feb; 49(2):439-44. PubMed ID: 6800252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of nitrates in congestive heart failure.
    Cohn JN
    Am J Cardiol; 1987 Nov; 60(15):39H-43H. PubMed ID: 3120564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic and metabolic effects of isosorbide dinitrate in chronic congestive heart failure.
    Gray R; Chatterjee K; Vyden JK; Ganz W; Forrester JS; Swan HJ
    Am Heart J; 1975 Sep; 90(3):346-52. PubMed ID: 1163426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.